A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein
Clinical trial NCT03773068 · COMPLETED
Trial details
- NCT number
- NCT03773068
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2019-06-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.